Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes

Small cell lung cancer (SCLC) is an aggressive tumor type with early dissemination and distant metastasis capacity. Even though optimal chemotherapy responses are observed initially in many patients, therapy resistance is almost inevitable. Accordingly, SCLC has been regarded as an archetype for can...

Descripción completa

Detalles Bibliográficos
Autores principales: Kursunel, M. Alper, Taskiran, Ekim Z., Tavukcuoglu, Ece, Yanik, Hamdullah, Demirag, Funda, Karaosmanoglu, Beren, Ozbay, Feyza Gul, Uner, Aysegul, Esendagli, Dorina, Kizilgoz, Derya, Yilmaz, Ulku, Esendagli, Gunes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783896/
https://www.ncbi.nlm.nih.gov/pubmed/34228218
http://dx.doi.org/10.1007/s00262-021-02998-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783896/
https://www.ncbi.nlm.nih.gov/pubmed/34228218
http://dx.doi.org/10.1007/s00262-021-02998-1

Ejemplares similares